This product is a human antibody targeting Human Ganglioside GD3. This antibody can be used inn the treatment of cancers expressing this antigen.
Figure 1 MAb MB3.6-mediated cytotoxicity of human melanoma cells in the presence of human complement.
The specific lysis was determined for five human melanoma cell lines that were labeled with 51Cr and challenged with MAb MB3.6 in the presence of human complement as described.
Cheresh, D. A., Honsik, C. J., Staffileno, L. K., Jung, G., & Reisfeld, R. A. (1985). Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. Proceedings of the National Academy of Sciences, 82(15), 5155-5159.
Figure 2 ADCC of M21 human melanoma cells mediated by Mab MB3.6 and effector cells from patients with melanoma.
The specific lysis was determined for M21 human melanoma cells that were labeled with 51Cr and challenged with human peripheral blood mononuclear cells isolated from three patients with advanced melanoma or one normal individual.
Cheresh, D. A., Honsik, C. J., Staffileno, L. K., Jung, G., & Reisfeld, R. A. (1985). Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. Proceedings of the National Academy of Sciences, 82(15), 5155-5159.
Figure 3 ADCC of human melanoma target cells mediated by MAb MB3.6 and normal human effector cells.
Cheresh, D. A., Honsik, C. J., Staffileno, L. K., Jung, G., & Reisfeld, R. A. (1985). Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. Proceedings of the National Academy of Scices, 82(15), 5155-5159.
Figure 4 Effects of MAb MB3.6 on the growth of A375p human melanoma cells expressing small amounts of GD3.
Cheresh, D. A., Honsik, C. J., Staffileno, L. K., Jung, G., & Reisfeld, R. A. (1985). Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. Proceedings of the National Academy of Scices, 82(15), 5155-5159.
Figure 5 Effects of MAb MB3.6 on human melanoma tumor formation in nude mice.
Cheresh, D. A., Honsik, C. J., Staffileno, L. K., Jung, G., & Reisfeld, R. A. (1985). Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. Proceedings of the National Academy of Scices, 82(15), 5155-5159.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1247WJ-S(P) | Human Anti-Ganglioside GD3 Recombinant Antibody (clone MB3.6); scFv Fragment | ELISA | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1247WJ-F(E) | Human Anti-Ganglioside GD3 Recombinant Antibody (clone MB3.6); Fab Fragment | ELISA | Human Fab |
There are currently no Customer reviews or questions for HPAB-1247WJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.